| Literature DB >> 25015823 |
Paulina Wochal1, Vijay A K Rathinam2, Aisling Dunne1, Thaddeus Carlson3, Wen Kuang4, Katherine J Seidl3, J Perry Hall3, Lih-Ling Lin3, Mary Collins3, Stefan A Schattgen2, Christopher R MacKay2, Caio T Fagundes1, Susan Carpenter5, Katherine A Fitzgerald2, Luke A J O'Neill6.
Abstract
TLR4 interactor with leucine-rich repeats (TRIL) is a brain-enriched accessory protein that is important in TLR3 and TLR4 signaling. In this study, we generated Tril(-/-) mice and examined TLR responses in vitro and in vivo. We found a role for TRIL in both TLR4 and TLR3 signaling in mixed glial cells, consistent with the high level of expression of TRIL in these cells. We also found that TRIL is a modulator of the innate immune response to LPS challenge and Escherichia coli infection in vivo. Tril(-/-) mice produce lower levels of multiple proinflammatory cytokines and chemokines specifically within the brain after E. coli and LPS challenge. Collectively, these data uncover TRIL as a mediator of innate immune responses within the brain, where it enhances neuronal cytokine responses to infection.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25015823 PMCID: PMC5503690 DOI: 10.4049/jimmunol.1302392
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422